A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline.
Rudnick, Paul A; Markey, Sanford P; Roth, Jeri; Mirokhin, Yuri; Yan, Xinjian; Tchekhovskoi, Dmitrii V; Edwards, Nathan J; Thangudu, Ratna R; Ketchum, Karen A; Kinsinger, Christopher R; Mesri, Mehdi; Rodriguez, Henry; Stein, Stephen E.
J Proteome Res
; 15(3): 1023-32, 2016 Mar 04.
Artigo em Inglês | MEDLINE | ID: mdl-26860878
A proteome-scale map of the human interactome network.
Sieving through the cancer secretome.
Recent findings from the Human Proteome Project: opening the mass spectrometry toolbox to advance cancer diagnosis, surveillance and treatment.
Drafting the proteome landscape of myeloid-derived suppressor cells.
Interstitial fluid-a reflection of the tumor cell microenvironment and secretome.
The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go.
MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1.
Linking cancer genome to proteome: NCI's investment into proteogenomics.